• Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 prnasia
    April 14, 2020
    Biological engineering company Ligandal, Inc. is applying its unique peptide-based delivery technologies to develop a prospective antidote and vaccine for SARS-CoV-2 (the novel coronavirus) to be formulated and developed in response to the worldwide pande
PharmaSources Customer Service